Join me as we finish our discussion on anueplody screening. In this episode we discuss the risks of amniocentisis and chorionic villus sampling, cell-free DNA, and different screening strategies.

Comparing Different Strategies

The assessment of combined first trimester screening in women of advanced maternal age in an Asian cohort

Amnio/CVS

A report of the safety and accuracy of midtrimester amniocentesis at the Medical College of Georgia: Eight and one half years' experience

PRENATAL DIAGNOSIS IN MULTIPLE GESTATION: 20 YEARS’ EXPERIENCE WITH AMNIOCENTESIS

Maternal complications following amniocentesis and chorionic villus sampling for prenatal karyotyping

Chorionic Villus Sampling

Fetal Complications of Amniocentesis

Intrauterine diagnosis and management of genetic defects

Role of Amniocentesis in the Intrauterine Detection of Genetic Disorders

Needle puncture of fetus: A complication of second- trimester amniocentesis

Fetal loss rate after chorionic villus sampling
and amniocentesis: an 11-year national registry study

Procedure-Related Complications of Amniocentesis and Chorionic Villous Sampling

Analysis of 2136 genetic amniocenteses: Experience of a single physician

Midtrimester amniocentesis: An analysis of 923 cases with neonatal follow-up

Cell-Free DNA

Presence of fetal DNA in maternal plasma and serum

Increased Fetal DNA Concentrations in the Plasma of Pregnant Women Carrying Fetuses with Trisomy 21

Single-Nucleotide Polymorphism–Based Noninvasive Prenatal Screening in a High-Risk and Low-Risk Cohort

Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma

Isolating fetal cells from maternal blood. Advances in prenatal diagnosis through molecular technology.

Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses

Noninvasive Prenatal Detection of Aneuploidy

Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection